Skip Nav Destination
New designs for phase 2 clinical trials
Prognosis of inv(16)/t(16;16) acute myeloid leukemia (AML): a survey of 110 cases from the French AML Intergroup
Graft-versus-host disease following allogeneic transplantation from HLA-identical sibling with antithymocyte globulin–based reduced-intensity preparative regimen
Melphalan-mobilized blood stem cell components contain minimal clonotypic myeloma cell contamination
Low frequency of CD94/NKG2A+ T lymphocytes in patients with HTLV-1–associated myelopathy/tropical spastic paraparesis, but not in asymptomatic carriers
Issue Archive
July 15 2003
In this Issue
Table of Contents
INSIDE BLOOD
PLENARY PAPERS
Comparative response of plasma VWF in dogs to up-regulation of VWF mRNA by interleukin-11 versus Weibel-Palade body release by desmopressin (DDAVP)
Eva H. N. Olsen,Arlene S. McCain,Elizabeth P. Merricks,Thomas H. Fischer,Ivy M. Dillon,Robin A. Raymer,Dwight A. Bellinger,Scot A. Fahs,Robert R. Montgomery,James C. Keith, Jr,Robert G. Schaub,Timothy C. Nichols
ERRATA
PERSPECTIVES
New designs for phase 2 clinical trials
Clinical Trials & Observations
REVIEW ARTICLES
CLINICAL OBSERVATIONS, INTERVENTIONS, AND THERAPEUTIC TRIALS
Prognosis of inv(16)/t(16;16) acute myeloid leukemia (AML): a survey of 110 cases from the French AML Intergroup
Clinical Trials & Observations
Jacques Delaunay,Norbert Vey,Thierry Leblanc,Pierre Fenaux,Françoise Rigal-Huguet,Francis Witz,Thierry Lamy,Anne Auvrignon,Didier Blaise,Arnaud Pigneux,Francine Mugneret,Christian Bastard,Nicole Dastugue,Jacqueline Van den Akker,Denis Fière,Josy Reiffers,Sylvie Castaigne,Guy Leverger,Jean-Luc Harousseau,Hervé Dombret,for the French Acute Myeloid Leukemia (AML) Intergroup including the Groupe Ouest-Est des Leucémies Aiguës Myéloblastiques (GOELAM), the Leucémies Aiguës Myéloblastiques de l'Enfant (LAME), the Acute Leukemia French Association (ALFA), and the Bordeaux-Grenoble-Marseille-Toulouse (BGMT) cooperative groups
Graft-versus-host disease following allogeneic transplantation from HLA-identical sibling with antithymocyte globulin–based reduced-intensity preparative regimen
Clinical Trials & Observations
Mohamad Mohty,Jacques-Olivier Bay,Catherine Faucher,Bachra Choufi,Karin Bilger,Olivier Tournilhac,Norbert Vey,Anne-Marie Stoppa,Diane Coso,Christian Chabannon,Patrice Viens,Dominique Maraninchi,Didier Blaise
Melphalan-mobilized blood stem cell components contain minimal clonotypic myeloma cell contamination
Clinical Trials & Observations
Brief Report
GENE THERAPY
HEMATOPOIESIS
HEMOSTASIS, THROMBOSIS, AND VASCULAR BIOLOGY
Asp1424Asn MYH9 mutation results in an unstable protein responsible for the phenotypes in May-Hegglin anomaly/Fechtner syndrome
Samuel Deutsch,Alexandra Rideau,Marie-Luce Bochaton-Piallat,Giuseppe Merla,Antoine Geinoz,Giulio Gabbiani,Torsten Schwede,Thomas Matthes,Stylianos E. Antonarakis,Photis Beris
Functional phenotype of phosphoinositide 3-kinase p85α-null platelets characterized by an impaired response to GP VI stimulation
Naohide Watanabe,Hideaki Nakajima,Hidenori Suzuki,Atsushi Oda,Yumiko Matsubara,Masaaki Moroi,Yasuo Terauchi,Takashi Kadowaki,Harumi Suzuki,Shigeo Koyasu,Yasuo Ikeda,Makoto Handa
Founder von Willebrand factor haplotype associated with type 1 von Willebrand disease
Lee A. O'Brien,Paula D. James,Maha Othman,Ergul Berber,Cherie Cameron,Colleen R. P. Notley,Carol A. Hegadorn,Jeffrey J. Sutherland,Christine Hough,Georges E. Rivard,Denise O'Shaunessey,David Lillicrap,the Association of Hemophilia Clinic Directors of Canada
IMMUNOBIOLOGY
Low frequency of CD94/NKG2A+ T lymphocytes in patients with HTLV-1–associated myelopathy/tropical spastic paraparesis, but not in asymptomatic carriers
Clinical Trials & Observations
Mineki Saito,Veronique M. Braud,Peter Goon,Emmanuel Hanon,Graham P. Taylor,Akiko Saito,Nobutaka Eiraku,Yuetsu Tanaka,Koichiro Usuku,Jonathan N. Weber,Mitsuhiro Osame,Charles R. M. Bangham
The minor histocompatibility antigen HA-3 arises from differential proteasome–mediated cleavage of the lymphoid blast crisis (Lbc) oncoprotein
Eric Spierings,Anthony G. Brickner,Jennifer A. Caldwell,Suzanne Zegveld,Nia Tatsis,Els Blokland,Jos Pool,Richard A. Pierce,Sahana Mollah,Jeffrey Shabanowitz,Laurence C. Eisenlohr,Peter Van Veelen,Ferry Ossendorp,Donald F. Hunt,Els Goulmy,Victor H. Engelhard
NEOPLASIA
Proangiogenic properties of human myeloma cells: production of angiopoietin-1 and its potential relationship to myeloma-induced angiogenesis
Nicola Giuliani,Simona Colla,Mirca Lazzaretti,Roberto Sala,Giovanni Roti,Cristina Mancini,Sabrina Bonomini,Paolo Lunghi,Magda Hojden,Giovenzio Genestreti,Mirija Svaldi,Paolo Coser,Pier Paolo Fattori,Gabriella Sammarelli,Gian Carlo Gazzola,Regis Bataille,Camillo Almici,Cecilia Caramatti,Lina Mangoni,Vittorio Rizzoli
Depsipeptide (FR901228) induces histone acetylation and inhibition of histone deacetylase in chronic lymphocytic leukemia cells concurrent with activation of caspase 8–mediated apoptosis and down-regulation of c-FLIP protein
Jennifer L. Aron,Mark R. Parthun,Guido Marcucci,Shinichi Kitada,Andrew P. Mone,Melanie E. Davis,Tiansheng Shen,Timothy Murphy,Joseph Wickham,Chris Kanakry,David M. Lucas,John C. Reed,Michael R. Grever,John C. Byrd
PHAGOCYTES
Oxidative stress is a critical mediator of the angiotensin II signal in human neutrophils: involvement of mitogen-activated protein kinase, calcineurin, and the transcription factor NF-κB
Rajaa El Bekay,Moisés Álvarez,Javier Monteseirín,Gonzalo Álba,Pedro Chacón,Antonio Vega,José Martín-Nieto,Juan Jiménez,Elízabeth Pintado,Francisco J. Bedoya,Francisco Sobrino
RED CELLS
TRANSFUSION MEDICINE
TRANSPLANTATION
Long-term remission in mantle cell lymphoma following high-dose sequential chemotherapy and in vivo rituximab-purged stem cell autografting (R-HDS regimen)
Alessandro M. Gianni,Michele Magni,Maurizio Martelli,Massimo Di Nicola,Carmelo Carlo-Stella,Silvana Pilotti,Alessandro Rambaldi,Sergio Cortelazzo,Caterina Patti,Guido Parvis,Fabio Benedetti,Saveria Capria,Paolo Corradini,Corrado Tarella,Tiziano Barbui
CORRESPONDENCE
-
Cover Image
Cover Image
Advertisement intended for health care professionals
Email alerts
Advertisement intended for health care professionals